Related Experiment Video
Updated: May 22, 2026

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
Published on: July 13, 2017
Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS
Alan Pestronk1, Robert E Schmidt, Rati M Choksi
1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. pestronka@neuro.wustl.edu
Introduction:
In this investigation we studied clinical and laboratory features of polyneuropathies in patients with serum IgM binding to the trisulfated disaccharide IdoA2S-GlcNS-6S (TS-HDS).
Methods:
We retrospectively compared 58 patients with selective IgM binding to TS-HDS to 41 consecutive patients with polyneuropathies without TS-HDS binding.
Results:
Patients with IgM vs. TS-HDS commonly had distal, sensory, axonal neuropathies. Weakness was associated with IgM M-proteins. Hand pain and serum IgM M-proteins were more common than in control neuropathy patients. TS-HDS antibody binding was often selectively κ class. Biopsies showed capillary pathology with thickened basal lamina and C5b9 complement deposition. IgM in sera with TS-HDS antibodies often bound to capillaries.
Conclusions:
Serum IgM binding to TS-HDS is associated with painful, sensory > motor, polyneuropathies with an increased frequency of persistent hand discomfort, serum IgM M-proteins, and capillary pathology. Serum IgM binding to TS-HDS suggests a possible immune etiology underlying some otherwise idiopathic sensory polyneuropathies.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Encephalitis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Type I Diabetes III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis

